Pharmaceutical manufacturers are encountering persistent logjams in secondary packaging and sterile fill-finish capacity for injectable GLP-1 receptor agonists.
Contract Manufacturing Demand
Contract Development and Manufacturing Organizations are securing multi-year capacity reservation contracts as pharmaceutical majors struggle to satisfy global volume requirements internally.